Latest Insider Transactions at Better Therapeutics, Inc. (BTTX)
This section provides a real-time view of insider transactions for Better Therapeutics, Inc. (BTTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Better Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Better Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 14
2021
|
Mark Heinen Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
500
+6.12%
|
$2,500
$5.44 P/Share
|
|
Dec 13
2021
|
Andrew J. Armanino |
BUY
Open market or private purchase
|
Indirect |
21,000
+19.57%
|
$105,000
$5.48 P/Share
|
|
Dec 13
2021
|
Mark Heinen Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
500
+6.52%
|
$2,500
$5.45 P/Share
|
|
Dec 10
2021
|
Kevin J Appelbaum Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+33.33%
|
$5,000
$5.98 P/Share
|
|
Dec 03
2021
|
Elder Granger |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$6,000
$6.66 P/Share
|
|
Dec 03
2021
|
Kevin J Appelbaum Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
500
+33.33%
|
$3,000
$6.43 P/Share
|
|
Dec 02
2021
|
Kevin J Appelbaum Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
500
+50.0%
|
$3,000
$6.84 P/Share
|
|
Nov 29
2021
|
Andrew J. Armanino |
BUY
Open market or private purchase
|
Indirect |
17,000
+20.65%
|
$102,000
$6.96 P/Share
|
|
Oct 28
2021
|
Mark Heinen Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,667
+16.67%
|
-
|
|
Oct 28
2021
|
Andrew J. Armanino |
BUY
Grant, award, or other acquisition
|
Indirect |
48,328
+43.94%
|
-
|
|
Oct 28
2021
|
Andrew J. Armanino |
BUY
Grant, award, or other acquisition
|
Direct |
13,334
+50.0%
|
-
|
|
Oct 28
2021
|
Geoffrey M. Parker |
BUY
Grant, award, or other acquisition
|
Indirect |
33,333
+50.0%
|
-
|
|
Oct 28
2021
|
Suying Liu Director |
BUY
Other acquisition or disposition
|
Indirect |
1,402,500
+50.51%
|
-
|
|
Oct 28
2021
|
Richard H Carmona |
BUY
Grant, award, or other acquisition
|
Direct |
153,619
+50.0%
|
-
|
|
Oct 28
2021
|
David P Perry Executive Chairman |
BUY
Grant, award, or other acquisition
|
Indirect |
10,578,501
+13.43%
|
$105,785,010
$10.0 P/Share
|
|
Oct 28
2021
|
David P Perry Executive Chairman |
BUY
Open market or private purchase
|
Indirect |
200,000
+1.83%
|
$2,000,000
$10.0 P/Share
|
|
May 26
2021
|
David P Perry Executive Chairman |
BUY
Open market or private purchase
|
Direct |
20,000
+27.96%
|
$180,000
$9.95 P/Share
|
|
May 24
2021
|
David P Perry Executive Chairman |
BUY
Open market or private purchase
|
Direct |
8,000
+20.23%
|
$72,000
$9.94 P/Share
|
|
May 21
2021
|
David P Perry Executive Chairman |
BUY
Open market or private purchase
|
Direct |
8,000
+25.37%
|
$72,000
$9.95 P/Share
|
|
May 14
2021
|
David P Perry Executive Chairman |
BUY
Open market or private purchase
|
Direct |
3,060
+16.46%
|
$27,540
$9.93 P/Share
|
|
May 13
2021
|
David P Perry Executive Chairman |
BUY
Open market or private purchase
|
Direct |
7,000
+35.94%
|
$63,000
$9.93 P/Share
|
|
May 04
2021
|
David P Perry Executive Chairman |
BUY
Open market or private purchase
|
Direct |
3,476
+38.83%
|
$31,284
$9.93 P/Share
|
|
Apr 30
2021
|
David P Perry Executive Chairman |
BUY
Open market or private purchase
|
Direct |
2,000
+50.0%
|
$18,000
$9.95 P/Share
|
|
Apr 07
2021
|
Dong Liu Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
200,000
-12.71%
|
$1,800,000
$9.0 P/Share
|
|
Apr 07
2021
|
Mountain Crest Capital LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
200,000
-12.71%
|
$1,800,000
$9.0 P/Share
|
|
Apr 07
2021
|
Suying Liu Director |
SELL
Open market or private sale
|
Indirect |
200,000
-12.71%
|
$1,800,000
$9.0 P/Share
|
|
Jan 14
2021
|
Dong Liu Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
7,500
+0.47%
|
$75,000
$10.0 P/Share
|
|
Jan 14
2021
|
Suying Liu Director |
BUY
Open market or private purchase
|
Indirect |
7,500
+0.47%
|
$75,000
$10.0 P/Share
|
|
Jan 14
2021
|
Mountain Crest Capital LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
7,500
+0.47%
|
$75,000
$10.0 P/Share
|
|
Jan 12
2021
|
Dong Liu Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
135,000
+7.93%
|
$1,350,000
$10.0 P/Share
|
|
Jan 12
2021
|
Suying Liu Director |
BUY
Open market or private purchase
|
Indirect |
135,000
+7.93%
|
$1,350,000
$10.0 P/Share
|
|
Jan 12
2021
|
Mountain Crest Capital LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
135,000
+7.93%
|
$1,350,000
$10.0 P/Share
|